Go Pro

Ardent Health, Inc. (NYSE:ARDT) Stock Has Consensus Target Price of $12.79 According to Brokerages

Ardent Health logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Analyst consensus is “Hold” for Ardent Health, with seven buy, six hold and two sell ratings. The average 12-month price target is $12.79, versus the stock’s recent price of $10.56.
  • Recent analyst actions were mixed but included target-price increases from Guggenheim and RBC, while BMO initiated coverage with a “market perform” rating and an $11 target.
  • Ardent Health reported quarterly EPS of $0.12, below the $0.18 consensus estimate, although revenue of $1.62 billion exceeded expectations. The company provided FY 2026 EPS guidance of $0.78–$1.15.
  • Five stocks we like better than Ardent Health.

Shares of Ardent Health, Inc. (NYSE:ARDT - Get Free Report) have received an average recommendation of "Hold" from the fifteen brokerages that are covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a sell recommendation, six have assigned a hold recommendation and seven have assigned a buy recommendation to the company. The average twelve-month price objective among brokerages that have issued ratings on the stock in the last year is $12.79.

Several equities analysts have recently weighed in on the stock. Guggenheim lifted their target price on shares of Ardent Health from $13.00 to $14.00 and gave the stock a "buy" rating in a research note on Thursday, August 6th. Royal Bank Of Canada upped their price target on shares of Ardent Health from $12.00 to $13.00 and gave the company an "outperform" rating in a research note on Monday, August 10th. Weiss Ratings downgraded shares of Ardent Health from a "sell (d+)" rating to a "sell (d)" rating in a report on Tuesday, August 11th. Zacks Research upgraded shares of Ardent Health from a "strong sell" rating to a "hold" rating in a research note on Monday, September 7th. Finally, BMO Capital Markets started coverage on shares of Ardent Health in a report on Tuesday. They set a "market perform" rating and a $11.00 target price on the stock.

Check Out Our Latest Analysis on ARDT

Institutional Trading of Ardent Health

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. BlackRock Inc. bought a new stake in Ardent Health during the 2nd quarter worth approximately $21,415,000. Algert Global LLC boosted its holdings in Ardent Health by 1,277.3% in the 2nd quarter. Algert Global LLC now owns 597,745 shares of the company's stock valued at $5,882,000 after purchasing an additional 554,345 shares during the period. Empowered Funds LLC purchased a new position in shares of Ardent Health during the 2nd quarter valued at $5,425,000. Bank of America Corp DE purchased a new position in shares of Ardent Health during the 2nd quarter valued at $3,840,000. Finally, Bank of New York Mellon Corp bought a new position in shares of Ardent Health in the second quarter worth $2,377,000.

Ardent Health Stock Up 0.8%

Shares of NYSE ARDT opened at $10.56 on Friday. The company has a debt-to-equity ratio of 0.61, a current ratio of 2.10 and a quick ratio of 1.99. The stock has a market capitalization of $1.49 billion, a PE ratio of 19.21, a P/E/G ratio of 2.97 and a beta of 0.71. Ardent Health has a one year low of $7.71 and a one year high of $15.48. The business's fifty day moving average price is $10.87 and its 200-day moving average price is $9.94.

Ardent Health (NYSE:ARDT - Get Free Report) last announced its quarterly earnings data on Tuesday, August 4th. The company reported $0.12 earnings per share for the quarter, missing the consensus estimate of $0.18 by ($0.06). The firm had revenue of $1.62 billion during the quarter, compared to analysts' expectations of $1.59 billion. Ardent Health had a return on equity of 10.35% and a net margin of 1.22%.Ardent Health has set its FY 2026 guidance at 0.780-1.150 EPS. On average, equities research analysts anticipate that Ardent Health will post 0.96 EPS for the current year.

About Ardent Health

(Get Free Report)

Ardent Health is a U.S. healthcare provider that owns and operates hospitals, outpatient facilities and other healthcare services. The company delivers a broad range of medical care, including emergency services, inpatient and outpatient treatment, primary care, specialty care, surgical services, behavioral health and urgent care.

Headquartered in Nashville, Tennessee, Ardent serves communities through a network of hospitals and healthcare sites in several states, including Texas, Oklahoma, New Mexico and Kansas.

See Also

Analyst Recommendations for Ardent Health (NYSE:ARDT)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Ardent Health Right Now?

Before you consider Ardent Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ardent Health wasn't on the list.

While Ardent Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines